Learn how AI can provide practical value across today’s CNS clinical trial journey in eCOA, image processing, and rater training in this free webinar. Attendees will gain insight into the role of AI-assisted vocal biomarkers in enhancing and accelerating the development of psychiatric therapeutics. Featured speakers will discuss the role of AI-powered MADRS interview quality analysis in rater training and rater supervision during the conduct of psychiatric research. Attendees will learn how comprehensive and responsible use of AI across imaging workflows improves data quality and patient safety, and unlocks new biomarkers for neuroimaging trials. Speakers will share insights on responsible use frameworks for the development and deployment of AI in clinical trials, including training, validation, human oversight, and awareness of the regulatory environment.
Toronto, April 22, 2026 /PRNewswire/ — Neuroscience clinical trials require highly accurate and sensitive endpoint measurements, but sponsors often face challenges such as subjective endpoints, rater variability, patient burden, and time-consuming data analysis.
This webinar explores how AI can address these challenges across neuroscience clinical trials. When developed and applied responsibly, AI can improve data quality and accuracy, increase the consistency of clinical assessments across multiple institutions, and support the identification of additional data insights beyond the capabilities of human experts.
www.clario.com
Clario’s scientific and AI experts will share how AI-enabled solutions are being applied to today’s neuroscience trials, including new audio biomarkers, MADRS rater training, quality monitoring, and innovative image analysis techniques. Participants will leave with a clearer understanding of where AI can add meaningful value to CNS exams.
Register for this webinar to learn how AI can bring greater precision, insight, and confidence to the conduct of neuroscience trials.
Join Clario experts Todd Rudo (Moderator), MD, EVP, Chief Medical Officer. Dr. Mark Opler, Chief Research Officer, eCOA Neuroscience Division; Alex Boudreau, AI Director. and Joël Schaerer, Ph.D., Senior Director, Imaging AI, will be on stage for a live webinar on Wednesday, May 13, 2026, at 11:00 a.m. ET (5:00 p.m. CEST/EU-CEST).
For more information or to register for this event, please see Neuroscience Drug Development: How Novel Applications of AI are Meaningfully Disrupting Traditional Development Strategies.
About XTALKS
Xtalks — Life Science Community™ provides pharmaceutical, biotech, medtech, healthcare, and research professionals with trusted knowledge and collaborative insights that move the industry forward. In partnership with Honeycomb Worldwide Inc., Xtalks provides news, features, webinars, podcasts, videos, expert interviews, curated job listings and more designed to support informed decision-making in a rapidly evolving field.
Thousands of professionals rely on Xtalks every year for timely intelligence, peer perspectives, and industry thought leadership. Join the life sciences community to stay informed, connected, and ready for what’s next.
For more information about Xtalks, please visit www.xtalks.com.
To learn how to partner with Xtalks to host a webinar, visit https://xtalks.com/partner-with-us/.
contact:
vera kovacevich
Phone: +1 (416) 977-6555 x371
Email: [email protected]
Source Xtalks
